Analysis News

  • The best newsletter in the market
  • Customisable and personal
  • By e-mail every morning, for free

Receive Analysis News:

EMail:

Free daily newsletter every morning

Content
Signals
All indicators - Medium term
DSVJul 17, 2019
Nordea BankJul 17, 2019
DLHJul 17, 2019
OMX Copenhagen Oil & GJul 17, 2019
OMX Copenhagen Oil & GJul 17, 2019
Events 2019
   
 

The market showed a small loss Wednesday, and OMX Copenhagen 25 GI (OMXC25GI) ended the day at 1202 points, which is a decline of 0.20 percent.

49 shares were up and 71 were down, while 27 remained unchanged, and there was no trading in 14 shares.

Total value of the trading volume for shares and primary capital certificates Wednesday was approximately 4.4 billion.

D/S Norden (DNORD) was up 1.40 percent to close at 109 kroner. The stock thereby broke the earlier top it set May 1 and reached a new year-high. The stock has thereby closed up 12 out of the past 16 days and this past month the stock has gained as much as 18.97 percent. Technically it also looks good. The stock is trend wise negative in the medium term, but has broken up through the resistance at 107 kroner.
H+H International (HH) closed at 99.80 kroner after a loss of 0.99 percent. The stock therby broke below the 100 -mark for the first time since Apr 2. The stock is trend wise positive in the medium term.
Nordea Bank (NDADK) ended with a steep loss of 2.94 percent and closed at 49.15 kroner. The previous time the stock lost this much was Mar 28, when it closed down 4.38 percent. The stock thereby reversed down after five days of gains. It does not look good technically either. The stock is trend wise negative in the medium term, but is testing the support at 49.00 kroner.
Chr. Hansen Holding (CHR) developed negatively and fell 1.41 percent to a close of 587 kroner. The stock has not closed at a lower price since Jan 4. The stock has thereby closed down 16 out of the past 20 days and this past month the stock has lost as much as 18.87 percent. The stock is testing the support at 582 kroner.
Novozymes B (NZYMB) closed at 315 kroner after a small gain of 0.54 percent. The stock has now closed up for the fifth day in a row. Technically, however, it does not look good. The stock is testing the resistance at 317 kroner.

US 500 reversed downwards
The market showed a small loss Tuesday, and S&P 500 (SP500) ended the day at 3004 points, which is a decline of 0.34 percent. The index thereby reversed down after five days of gains.

Negative development on Stockholmsbörsen Wednesday
OMX Stockholm PI (OMXSPI) developed negatively Wednesday, and fell 1.24 percent to a close of 613 points.

Indices
OMX Copenhagen 25 GI
   Weak Negative Candidate
OMX Copenhagen 25 GI has broken the floor of the rising trend channel in the medium long term, which indicates a weaker initial rising rate. The index is testing the resistance at points 1206, which may give a negative reaction. The index is assessed as technically slightly negative for the medium long term.
S&P 500
   Weak Positive Candidate
S&P 500 is in a rising trend channel in the medium long term. This shows that investors over time have bought the index at higher prices and indicates good development for the market. The index has support at points 2930. RSI is above 70 after a good price increase the past weeks. The index has strong positive momentum and further increase is indicated. However, particularly for big stocks, high RSI may be a sign that the stock is overbought and that there is a chance of a reaction downwards. The index is overall assessed as technically slightly positive for the medium long term.
OMX Stockholm PI
   Weak Negative Candidate
OMX Stockholm PI shows strong development within a rising trend channel in the medium long term. Rising trends indicate that the market experiences positive development and that buy interest among investors is increasing. The index has broken a support level in the short term and given a negative signal for the short term trading range. The index has broken down through the support at points 618. This predicts a further decline. In case of positive reactions, there will now be resistance at points 618. The RSI curve shows a falling trend, which is an early signal for a possible trend reversal downwards for the price as well. The index is overall assessed as technically slightly negative for the medium long term.
Today´s Case
DSV (DSV) Price 651.60, Jul 17, 2019
DSV shows strong development within a rising trend channel in the medium long term. Rising trends indicate that the company experiences positive development and that buy interest among investors is increasing. The stock has broken a resistance level in the short term and given a positive signal for the short-term trading range. The stock has support at kroner 600. Negative volume balance weakens the stock in the short term. The RSI curve shows a falling trend, which is an early signal for a possible trend reversal downwards for the price as well. The stock is overall assessed as technically slightly positive for the medium long term.
Recommendation: Weak Positive
Model Portfolio, Københavns fondsbørs
Portfolio:2778.73
Ref.idx:225.91
 Last week20192018
Portfolio   0.89%   17.12%   31.67%
Portfolio after commisio   0.83%   16.02%   29.12%
OMX Copenhagen 25 GI   -0.53%   15.80%   -11.19%
Latest days indices
AEX0.20%572.34
ATX0.00%3406.09
CAC40-0.76%5571.71
COMPX-0.43%8222.80
DAX0.35%12431
HEX-0.93%9393.41
N100-0.47%1081.27
OMXC25GI-0.20%1202.42
OMXSPI-1.24%613.38
OSEBX-0.72%867.84
PSI200.07%5263.54
TECDAX-0.34%2894.21
UKX-0.55%7535.46
EURUSD0.10%112.2789
CL (OIL)-3.29%57.62
Indices Evaluations
 SML
AEXposposneutral
ATXneutralneutralneutral
CAC40negpospos
COMPXpospospos
DAXpospospos
HEXposnegpos
N100posneutralpos
OMXC25GIposnegpos
OMXSPIposnegpos
OSEBXneutralneutralpos
PSI20posnegneg
TECDAXposneutralpos
UKXpospospos
EURUSDneutralneutralneg
CL (OIL)neutralneutralneutral

S: Short term.    M: Medium term.    L: Long term.
Stock Exchange barometer
Københavns Fondsbørs - Medium term
 
      
29% 53% 18%
 58 Buy Candidates
 105 Neutral
 35 Sell Candidates
Cancel Analysis News
Disclaimer Copyright © 2019 Investtech.com AS, Org nr 978 655 424 MVA


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

[ Back to default newsletter setup ]

Customised newsletter

Investtech subscribers can customise AnalysisNews. Add your own stocks, your own portfolios, etc, and get the updates directly to your inbox. A customised newsletter is the best way to get a daily overview of the market and your own investments.
Wherever you see this button, you can click it in order to add a simplified version of the page to AnalysisNews or to your start page.

Edit AnalysisNews

Register as a recipient of AnalysisNews in order to customise the content.

Tilpass AnalyseNyt

Se hvordan du kan tilpasse AnalyseNyt til dine behov.



 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK